Test Price
2,800 AED✅ Home Collection Available
BRIP1 Gene Fanconi Anemia Type J Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary: The BRIP1 gene NGS sequencing test delivers diagnostic accuracy exceeding 99.9% through our internationally accredited laboratory. Premium home collection via temperature‑controlled cold‑chain logistics ensures sample integrity from your doorstep. Post‑test telephonic clinical guidance is included to help you understand results in the context of your personal and family history.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The BRIP1 NGS Genetic Test comprehensively screens the entire BRIP1 gene for pathogenic variants linked to Fanconi anemia type J and hereditary breast/ovarian cancer susceptibility. Our methodology uses complete next‑generation sequencing covering all exons and flanking intronic regions, ensuring detection of nucleotide substitutions, small insertions/deletions, and copy number variants.
| Feature | Our BRIP1 NGS Test | Closest Alternative |
|---|---|---|
| Technology | Complete NGS Gene Sequencing (all exons ± intron boundaries) | Single‑gene Sanger sequencing (limited coverage) |
| Clinical Sensitivity | 99.9% for nucleotide substitutions, small indels, & copy number variants* | ~95% (misses deep intronic or large rearrangements) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| ISO Certification | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | May vary |
*Validated against reference standard NA12878 and CAP‑accredited proficiency panels.
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I see the BRIP1 analysis as a cornerstone for diagnosing Fanconi anemia type J and stratifying hereditary cancer risk. Testing must always be accompanied by pre‑ and post‑test genetic counselling to ensure that results are properly contextualised within the patient’s clinical and family history. We recommend that all patients discuss findings with a haematologist or medical geneticist before making any health decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Important Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor.
This test does not replace ongoing medical treatment. If you are on anticoagulants or other medications, inform your phlebotomist; no dietary or medication changes are required for sample collection.
Test Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Recent allogeneic blood transfusion or stem cell transplant – may yield donor DNA and invalidate results. Wait at least 6 months post‑transfusion before testing.
- Inability to provide informed consent – for minors, legal guardian consent is mandatory per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Current severe hemolysis or acute hematopoietic crisis – sample collection may be unsafe; consult your haematologist first.
Emergency Red Flags
Seek immediate medical care if you experience: spontaneous severe bruising, persistent high fever, difficulty breathing, or recurrent infections unresponsive to standard treatment – these may indicate bone marrow failure and require urgent evaluation.
Patient FAQ & Clinical Guidance
1. What does the BRIP1 gene test detect?
The BRIP1 NGS analysis detects genetic mutations causing Fanconi anemia type J and hereditary cancer risks.
It provides a comprehensive assessment of the BRIP1 gene, which encodes a DNA repair protein. Pathogenic variants can confirm the clinical diagnosis of Fanconi anemia type J and also indicate a heightened lifetime risk for breast, ovarian, and other BRCA‑spectrum cancers. The test covers all coding exons and splice‑site junctions.
2. How accurate is this test and what does a positive result mean?
With sensitivity exceeding 99.9%, a positive BRIP1 result confirms a pathogenic variant requiring clinical correlation by a specialist.
A positive report indicates the presence of a disease‑causing mutation, but the clinical impact depends on your personal and family history. Genetic counselling is essential to understand surveillance and prevention options. Our team provides a telephonic post‑test consultation to walk you through the findings.
3. Do I need to prepare specially for the blood draw or DNA sample?
No fasting is required; simply provide blood or buccal swab after a genetic counselling session to document family history.
We will arrange a home collection; a small venous blood sample (3–5 mL in EDTA) or a DNA FTA card is sufficient. The genetic counselling ensures that the family pedigree is captured to maximise the utility of the test. Our mobile phlebotomist will visit your home between 8 AM and 11 PM.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Rights
DNA Labs UAE operates under the strictest data protection frameworks in the region. All genetic information is handled in compliance with:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, storage, and processing of personal data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health‑data exchange and patient consent.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – safeguarding patient consent and clinical accountability.
Your test results are encrypted, access‑controlled, and never shared without explicit written consent. We adhere to UAE’s health data governance standards to maintain the highest level of confidentiality.
Clinical & Logistical Metadata
| Test Name | BRIP1 Gene Fanconi Anemia Type J Genetic Test (NGS Sequencing) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Buccal Swab – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM – 11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene sequencing including all exons and intron‑exon boundaries |
| ICD‑10‑CM Code | D61.0 (Constitutional aplastic anemia – Fanconi anemia) |
| LOINC Code | 81213-0 (BRIP1 gene mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians